nodes	percent_of_prediction	percent_of_DWPC	metapath
Vismodegib—CYP2C8—Spironolactone—dilated cardiomyopathy	0.251	0.3	CbGbCtD
Vismodegib—ALB—Furosemide—dilated cardiomyopathy	0.222	0.266	CbGbCtD
Vismodegib—ABCB1—Lisinopril—dilated cardiomyopathy	0.193	0.231	CbGbCtD
Vismodegib—ABCB1—Spironolactone—dilated cardiomyopathy	0.17	0.203	CbGbCtD
Vismodegib—Sorafenib—RAF1—dilated cardiomyopathy	0.0107	1	CrCbGaD
Vismodegib—CYP2C9—cardial valve—dilated cardiomyopathy	0.00947	0.601	CbGeAlD
Vismodegib—Amenorrhoea—Spironolactone—dilated cardiomyopathy	0.00889	0.0741	CcSEcCtD
Vismodegib—Flank pain—Lisinopril—dilated cardiomyopathy	0.00792	0.066	CcSEcCtD
Vismodegib—Azotaemia—Lisinopril—dilated cardiomyopathy	0.00598	0.0499	CcSEcCtD
Vismodegib—Alopecia—Spironolactone—dilated cardiomyopathy	0.00347	0.0289	CcSEcCtD
Vismodegib—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00328	0.0274	CcSEcCtD
Vismodegib—Musculoskeletal pain—Lisinopril—dilated cardiomyopathy	0.00323	0.0269	CcSEcCtD
Vismodegib—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.0031	0.0258	CcSEcCtD
Vismodegib—Blood urea increased—Lisinopril—dilated cardiomyopathy	0.00301	0.0251	CcSEcCtD
Vismodegib—Dehydration—Furosemide—dilated cardiomyopathy	0.00287	0.0239	CcSEcCtD
Vismodegib—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.00281	0.0234	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00241	0.0201	CcSEcCtD
Vismodegib—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.00232	0.0194	CcSEcCtD
Vismodegib—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.00231	0.0193	CcSEcCtD
Vismodegib—SMO—heart—dilated cardiomyopathy	0.00219	0.139	CbGeAlD
Vismodegib—Dehydration—Lisinopril—dilated cardiomyopathy	0.00215	0.018	CcSEcCtD
Vismodegib—Breast disorder—Lisinopril—dilated cardiomyopathy	0.00209	0.0174	CcSEcCtD
Vismodegib—Pruritus—Spironolactone—dilated cardiomyopathy	0.00197	0.0164	CcSEcCtD
Vismodegib—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00191	0.0159	CcSEcCtD
Vismodegib—SMO—cardiac atrium—dilated cardiomyopathy	0.00187	0.119	CbGeAlD
Vismodegib—Malnutrition—Furosemide—dilated cardiomyopathy	0.00186	0.0155	CcSEcCtD
Vismodegib—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00182	0.0152	CcSEcCtD
Vismodegib—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00181	0.0151	CcSEcCtD
Vismodegib—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00179	0.0149	CcSEcCtD
Vismodegib—Vomiting—Spironolactone—dilated cardiomyopathy	0.00177	0.0148	CcSEcCtD
Vismodegib—Rash—Spironolactone—dilated cardiomyopathy	0.00176	0.0147	CcSEcCtD
Vismodegib—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00176	0.0146	CcSEcCtD
Vismodegib—Nausea—Spironolactone—dilated cardiomyopathy	0.00166	0.0138	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00157	0.0131	CcSEcCtD
Vismodegib—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00149	0.0124	CcSEcCtD
Vismodegib—Skin disorder—Furosemide—dilated cardiomyopathy	0.00147	0.0123	CcSEcCtD
Vismodegib—Alopecia—Lisinopril—dilated cardiomyopathy	0.00141	0.0118	CcSEcCtD
Vismodegib—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00139	0.0116	CcSEcCtD
Vismodegib—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00136	0.0114	CcSEcCtD
Vismodegib—Back pain—Lisinopril—dilated cardiomyopathy	0.00135	0.0112	CcSEcCtD
Vismodegib—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00134	0.0112	CcSEcCtD
Vismodegib—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00132	0.011	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00131	0.0109	CcSEcCtD
Vismodegib—Fatigue—Furosemide—dilated cardiomyopathy	0.00131	0.0109	CcSEcCtD
Vismodegib—Pain—Furosemide—dilated cardiomyopathy	0.0013	0.0108	CcSEcCtD
Vismodegib—Constipation—Furosemide—dilated cardiomyopathy	0.0013	0.0108	CcSEcCtD
Vismodegib—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00124	0.0103	CcSEcCtD
Vismodegib—Abdominal pain—Furosemide—dilated cardiomyopathy	0.0012	0.01	CcSEcCtD
Vismodegib—Myalgia—Lisinopril—dilated cardiomyopathy	0.00119	0.0099	CcSEcCtD
Vismodegib—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00119	0.0099	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00118	0.00983	CcSEcCtD
Vismodegib—Skin disorder—Lisinopril—dilated cardiomyopathy	0.0011	0.00921	CcSEcCtD
Vismodegib—Asthenia—Furosemide—dilated cardiomyopathy	0.00109	0.00907	CcSEcCtD
Vismodegib—Pruritus—Furosemide—dilated cardiomyopathy	0.00107	0.00895	CcSEcCtD
Vismodegib—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00104	0.00865	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00104	0.00864	CcSEcCtD
Vismodegib—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.001	0.00835	CcSEcCtD
Vismodegib—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000989	0.00825	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000982	0.00819	CcSEcCtD
Vismodegib—Fatigue—Lisinopril—dilated cardiomyopathy	0.000981	0.00818	CcSEcCtD
Vismodegib—Pain—Lisinopril—dilated cardiomyopathy	0.000973	0.00811	CcSEcCtD
Vismodegib—Constipation—Lisinopril—dilated cardiomyopathy	0.000973	0.00811	CcSEcCtD
Vismodegib—Vomiting—Furosemide—dilated cardiomyopathy	0.000964	0.00804	CcSEcCtD
Vismodegib—Rash—Furosemide—dilated cardiomyopathy	0.000956	0.00797	CcSEcCtD
Vismodegib—Dermatitis—Furosemide—dilated cardiomyopathy	0.000955	0.00796	CcSEcCtD
Vismodegib—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00093	0.00776	CcSEcCtD
Vismodegib—Nausea—Furosemide—dilated cardiomyopathy	0.000901	0.00751	CcSEcCtD
Vismodegib—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000899	0.0075	CcSEcCtD
Vismodegib—ALB—heart—dilated cardiomyopathy	0.000838	0.0532	CbGeAlD
Vismodegib—Asthenia—Lisinopril—dilated cardiomyopathy	0.000816	0.00681	CcSEcCtD
Vismodegib—SHH—Ectoderm Differentiation—DMD—dilated cardiomyopathy	0.000808	0.0423	CbGpPWpGaD
Vismodegib—Pruritus—Lisinopril—dilated cardiomyopathy	0.000805	0.00671	CcSEcCtD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.0008	0.0418	CbGpPWpGaD
Vismodegib—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000778	0.00649	CcSEcCtD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.000758	0.0397	CbGpPWpGaD
Vismodegib—Vomiting—Lisinopril—dilated cardiomyopathy	0.000723	0.00603	CcSEcCtD
Vismodegib—Rash—Lisinopril—dilated cardiomyopathy	0.000717	0.00598	CcSEcCtD
Vismodegib—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000717	0.00598	CcSEcCtD
Vismodegib—SMO—GPCRs, Other—CXCR3—dilated cardiomyopathy	0.000689	0.036	CbGpPWpGaD
Vismodegib—SHH—Validated transcriptional targets of TAp63 isoforms—FAS—dilated cardiomyopathy	0.000685	0.0358	CbGpPWpGaD
Vismodegib—Nausea—Lisinopril—dilated cardiomyopathy	0.000676	0.00563	CcSEcCtD
Vismodegib—ABCG2—heart—dilated cardiomyopathy	0.000573	0.0364	CbGeAlD
Vismodegib—SMO—GPCRs, Other—ADRB2—dilated cardiomyopathy	0.00054	0.0283	CbGpPWpGaD
Vismodegib—CYP2C9—heart—dilated cardiomyopathy	0.000523	0.0332	CbGeAlD
Vismodegib—SHH—Hair Follicle Development: Induction (Part 1 of 3)—EGFR—dilated cardiomyopathy	0.000373	0.0195	CbGpPWpGaD
Vismodegib—ABCB1—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.000363	0.019	CbGpPWpGaD
Vismodegib—SMO—Hair Follicle Development: Induction (Part 1 of 3)—EGFR—dilated cardiomyopathy	0.000354	0.0185	CbGpPWpGaD
Vismodegib—ABCB1—heart—dilated cardiomyopathy	0.000282	0.0179	CbGeAlD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.000259	0.0135	CbGpPWpGaD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.000249	0.013	CbGpPWpGaD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.000245	0.0128	CbGpPWpGaD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.000245	0.0128	CbGpPWpGaD
Vismodegib—ALB—Platelet degranulation—TTN—dilated cardiomyopathy	0.000242	0.0127	CbGpPWpGaD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.000236	0.0124	CbGpPWpGaD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.000232	0.0121	CbGpPWpGaD
Vismodegib—CYP2C19—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000232	0.0121	CbGpPWpGaD
Vismodegib—ALB—Response to elevated platelet cytosolic Ca2+—TTN—dilated cardiomyopathy	0.000231	0.0121	CbGpPWpGaD
Vismodegib—SHH—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000221	0.0116	CbGpPWpGaD
Vismodegib—SHH—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000221	0.0116	CbGpPWpGaD
Vismodegib—ALB—Platelet degranulation—ACTN2—dilated cardiomyopathy	0.00021	0.011	CbGpPWpGaD
Vismodegib—SMO—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00021	0.011	CbGpPWpGaD
Vismodegib—SMO—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00021	0.011	CbGpPWpGaD
Vismodegib—SHH—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000206	0.0108	CbGpPWpGaD
Vismodegib—ALB—Response to elevated platelet cytosolic Ca2+—ACTN2—dilated cardiomyopathy	0.0002	0.0105	CbGpPWpGaD
Vismodegib—SHH—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000199	0.0104	CbGpPWpGaD
Vismodegib—SMO—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000195	0.0102	CbGpPWpGaD
Vismodegib—SMO—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000189	0.00989	CbGpPWpGaD
Vismodegib—ALB—Platelet degranulation—VCL—dilated cardiomyopathy	0.000179	0.00934	CbGpPWpGaD
Vismodegib—SHH—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00017	0.00891	CbGpPWpGaD
Vismodegib—ALB—Response to elevated platelet cytosolic Ca2+—VCL—dilated cardiomyopathy	0.00017	0.0089	CbGpPWpGaD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	0.000162	0.00848	CbGpPWpGaD
Vismodegib—SHH—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000162	0.00845	CbGpPWpGaD
Vismodegib—SMO—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000161	0.00845	CbGpPWpGaD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	0.000154	0.00804	CbGpPWpGaD
Vismodegib—SMO—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000153	0.00801	CbGpPWpGaD
Vismodegib—ALB—Binding and Uptake of Ligands by Scavenger Receptors—CD36—dilated cardiomyopathy	0.00013	0.00683	CbGpPWpGaD
Vismodegib—SHH—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00012	0.00627	CbGpPWpGaD
Vismodegib—ALB—Vitamin B12 Metabolism—SOD2—dilated cardiomyopathy	0.000118	0.00617	CbGpPWpGaD
Vismodegib—CYP2C8—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000115	0.00601	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000114	0.00595	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000114	0.00595	CbGpPWpGaD
Vismodegib—SMO—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000114	0.00594	CbGpPWpGaD
Vismodegib—SHH—Disease—NPPA—dilated cardiomyopathy	0.000111	0.00583	CbGpPWpGaD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	0.000111	0.00582	CbGpPWpGaD
Vismodegib—SHH—Disease—PSEN2—dilated cardiomyopathy	0.000108	0.00565	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000108	0.00564	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000108	0.00564	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—TTN—dilated cardiomyopathy	0.000107	0.00562	CbGpPWpGaD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	0.000106	0.00554	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000106	0.00553	CbGpPWpGaD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	0.000105	0.00551	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.000103	0.00538	CbGpPWpGaD
Vismodegib—CYP2C19—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000103	0.00537	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000102	0.00535	CbGpPWpGaD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	0.0001	0.00525	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.0001	0.00524	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—ADRB1—dilated cardiomyopathy	9.7e-05	0.00507	CbGpPWpGaD
Vismodegib—ALB—Folate Metabolism—SOD2—dilated cardiomyopathy	9.6e-05	0.00502	CbGpPWpGaD
Vismodegib—CYP2C9—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	9.36e-05	0.0049	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—ACTN2—dilated cardiomyopathy	9.31e-05	0.00487	CbGpPWpGaD
Vismodegib—ALB—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	9.17e-05	0.0048	CbGpPWpGaD
Vismodegib—ALB—Folate Metabolism—GPX1—dilated cardiomyopathy	9.16e-05	0.00479	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—AGTR1—dilated cardiomyopathy	8.74e-05	0.00457	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—AGTR1—dilated cardiomyopathy	8.66e-05	0.00453	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—ADRB2—dilated cardiomyopathy	8.29e-05	0.00434	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—AGTR1—dilated cardiomyopathy	8.28e-05	0.00433	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—VCL—dilated cardiomyopathy	7.92e-05	0.00414	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—ADRB2—dilated cardiomyopathy	7.86e-05	0.00411	CbGpPWpGaD
Vismodegib—ABCG2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	7.77e-05	0.00406	CbGpPWpGaD
Vismodegib—ALB—Platelet degranulation—CD36—dilated cardiomyopathy	7.64e-05	0.004	CbGpPWpGaD
Vismodegib—ALB—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	7.62e-05	0.00399	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—PSEN2—dilated cardiomyopathy	7.56e-05	0.00396	CbGpPWpGaD
Vismodegib—ABCG2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	7.56e-05	0.00395	CbGpPWpGaD
Vismodegib—ABCG2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	7.56e-05	0.00395	CbGpPWpGaD
Vismodegib—ALB—Response to elevated platelet cytosolic Ca2+—CD36—dilated cardiomyopathy	7.28e-05	0.00381	CbGpPWpGaD
Vismodegib—ALB—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	7.27e-05	0.0038	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	7.25e-05	0.0038	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—PSEN2—dilated cardiomyopathy	7.17e-05	0.00375	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	7.11e-05	0.00372	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	7.07e-05	0.0037	CbGpPWpGaD
Vismodegib—ABCG2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	7.02e-05	0.00367	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	6.74e-05	0.00353	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—CXCL2—dilated cardiomyopathy	6.71e-05	0.00351	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—AGTR2—dilated cardiomyopathy	6.71e-05	0.00351	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	6.69e-05	0.0035	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	6.65e-05	0.00348	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	6.5e-05	0.0034	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—RAC1—dilated cardiomyopathy	6.44e-05	0.00337	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—AGTR2—dilated cardiomyopathy	6.36e-05	0.00333	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—CXCL2—dilated cardiomyopathy	6.36e-05	0.00333	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	6.35e-05	0.00332	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—CXCR3—dilated cardiomyopathy	6.24e-05	0.00327	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—AGT—dilated cardiomyopathy	6.15e-05	0.00322	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—RAC1—dilated cardiomyopathy	6.1e-05	0.00319	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—ADRB1—dilated cardiomyopathy	6.04e-05	0.00316	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	5.97e-05	0.00312	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—CXCR3—dilated cardiomyopathy	5.92e-05	0.0031	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—AGT—dilated cardiomyopathy	5.83e-05	0.00305	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	5.79e-05	0.00303	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—ADRB1—dilated cardiomyopathy	5.73e-05	0.003	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—TTN—dilated cardiomyopathy	5.54e-05	0.0029	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	5.44e-05	0.00285	CbGpPWpGaD
Vismodegib—SHH—Disease—RAC1—dilated cardiomyopathy	5.43e-05	0.00284	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.16e-05	0.0027	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—ANKRD1—dilated cardiomyopathy	5.11e-05	0.00267	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.9e-05	0.00256	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—AGTR1—dilated cardiomyopathy	4.89e-05	0.00256	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—ACTN2—dilated cardiomyopathy	4.8e-05	0.00251	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—TAZ—dilated cardiomyopathy	4.8e-05	0.00251	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	4.79e-05	0.00251	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	4.66e-05	0.00244	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	4.66e-05	0.00244	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.64e-05	0.00243	CbGpPWpGaD
Vismodegib—ALB—Vitamin B12 Metabolism—TNF—dilated cardiomyopathy	4.47e-05	0.00234	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—SDHA—dilated cardiomyopathy	4.34e-05	0.00227	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	4.33e-05	0.00227	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.27e-05	0.00223	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.21e-05	0.0022	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	4.2e-05	0.0022	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	4.08e-05	0.00214	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	4.08e-05	0.00214	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—VCL—dilated cardiomyopathy	4.08e-05	0.00214	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.05e-05	0.00212	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.99e-05	0.00209	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—RAC1—dilated cardiomyopathy	3.8e-05	0.00199	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	3.8e-05	0.00199	CbGpPWpGaD
Vismodegib—ALB—Folate Metabolism—TNF—dilated cardiomyopathy	3.64e-05	0.0019	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—AGT—dilated cardiomyopathy	3.63e-05	0.0019	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—RAC1—dilated cardiomyopathy	3.6e-05	0.00189	CbGpPWpGaD
Vismodegib—SHH—Disease—RAF1—dilated cardiomyopathy	3.6e-05	0.00188	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—AGT—dilated cardiomyopathy	3.44e-05	0.0018	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	3.39e-05	0.00177	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	3.33e-05	0.00174	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	3.21e-05	0.00168	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	3.2e-05	0.00167	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—ANKRD1—dilated cardiomyopathy	3.17e-05	0.00166	CbGpPWpGaD
Vismodegib—ALB—Metabolism—ANKRD1—dilated cardiomyopathy	3.15e-05	0.00165	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	3.15e-05	0.00165	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—TAZ—dilated cardiomyopathy	2.98e-05	0.00156	CbGpPWpGaD
Vismodegib—ALB—Metabolism—TAZ—dilated cardiomyopathy	2.96e-05	0.00155	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.93e-05	0.00153	CbGpPWpGaD
Vismodegib—ALB—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	2.89e-05	0.00151	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—ANKRD1—dilated cardiomyopathy	2.83e-05	0.00148	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.77e-05	0.00145	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	2.76e-05	0.00144	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	2.76e-05	0.00144	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—SDHA—dilated cardiomyopathy	2.69e-05	0.00141	CbGpPWpGaD
Vismodegib—ALB—Metabolism—SDHA—dilated cardiomyopathy	2.68e-05	0.0014	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—TAZ—dilated cardiomyopathy	2.66e-05	0.00139	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	2.6e-05	0.00136	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	2.58e-05	0.00135	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—RAF1—dilated cardiomyopathy	2.52e-05	0.00132	CbGpPWpGaD
Vismodegib—SHH—Disease—EGFR—dilated cardiomyopathy	2.47e-05	0.00129	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	2.42e-05	0.00127	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—SDHA—dilated cardiomyopathy	2.4e-05	0.00126	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—RAF1—dilated cardiomyopathy	2.39e-05	0.00125	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	2.35e-05	0.00123	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	2.19e-05	0.00115	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	2.12e-05	0.00111	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	2.09e-05	0.00109	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—ITGB1—dilated cardiomyopathy	2.05e-05	0.00107	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—CD36—dilated cardiomyopathy	1.75e-05	0.000914	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—EGFR—dilated cardiomyopathy	1.73e-05	0.000904	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	1.7e-05	0.00089	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—RAC1—dilated cardiomyopathy	1.65e-05	0.000862	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.64e-05	0.00086	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—EGFR—dilated cardiomyopathy	1.64e-05	0.000857	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.63e-05	0.000855	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.6e-05	0.000837	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	1.6e-05	0.000836	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.59e-05	0.000832	CbGpPWpGaD
Vismodegib—ABCG2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.53e-05	0.000802	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.47e-05	0.000767	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	1.45e-05	0.000756	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.44e-05	0.000754	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.43e-05	0.000749	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	1.43e-05	0.000748	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.43e-05	0.000747	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	1.36e-05	0.000713	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.34e-05	0.0007	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.3e-05	0.000681	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.29e-05	0.000673	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—GPX1—dilated cardiomyopathy	1.18e-05	0.000617	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.17e-05	0.000613	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—CD36—dilated cardiomyopathy	1.15e-05	0.000601	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—RAF1—dilated cardiomyopathy	1.09e-05	0.000571	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—AGT—dilated cardiomyopathy	1.03e-05	0.000541	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	9.45e-06	0.000495	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	8.28e-06	0.000433	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—GPX1—dilated cardiomyopathy	7.32e-06	0.000383	CbGpPWpGaD
Vismodegib—ALB—Metabolism—GPX1—dilated cardiomyopathy	7.28e-06	0.000381	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—CD36—dilated cardiomyopathy	7.13e-06	0.000373	CbGpPWpGaD
Vismodegib—ALB—Metabolism—CD36—dilated cardiomyopathy	7.09e-06	0.000371	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	6.53e-06	0.000342	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—AGT—dilated cardiomyopathy	6.42e-06	0.000336	CbGpPWpGaD
Vismodegib—ALB—Metabolism—AGT—dilated cardiomyopathy	6.38e-06	0.000334	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	6.38e-06	0.000334	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	6.36e-06	0.000333	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CD36—dilated cardiomyopathy	6.21e-06	0.000325	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	5.96e-06	0.000312	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	5.8e-06	0.000303	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	5.73e-06	0.0003	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—AGT—dilated cardiomyopathy	5.59e-06	0.000292	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	5.22e-06	0.000273	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	3.93e-06	0.000205	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	3.83e-06	0.0002	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	3.44e-06	0.00018	CbGpPWpGaD
